Could multimodal pharmacotherapies help us defeat obesity?

In recent decades, obesity has become a global epidemic. Dr David Loczenski, Business Development Manager at Sygnature, tells how a new class of multimodal pharmacotherapy drugs may hold a solution… According to the World Health Organisation, the prevalence of obesity has nearly tripled since 1975, with more than 1.9 billion adults now being overweight and … Continue reading Could multimodal pharmacotherapies help us defeat obesity?